IonQ, a leading quantum technology company, has announced a record-breaking advancement in protein folding, a critical ...

PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer ...

For the first time, scientists using cryo-electron microscopy have discovered the structure and shape of key receptors ...

Post-therapy imaging and dosimetry significantly enhance patient management, empowering clinicians to make more informed, ...

ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Health and the Aspen Ideas Festival deeply inspired—by the setting, the community, and the shared pursuit of progress,” Brendan G. Carr has told Digital Journal. “This year, my colleagues will explore ...

Objective To explore the association between biological rhythm and internalising disorders among children and adolescents. Design, setting and participants This cross-sectional study used data from ...

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...